CClinicalTrials.gg
Not yet recruitingNCT07803172Updated Sep 15, 2026

Artificial Intelligence-Supported Digital Game and Exercise Applications in Children With Autism and Typically Developing Children

An interventional study of Movement-Based Digital Game Intervention in Autism Disorder, sponsored by Burdur Mehmet Akif Ersoy University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Burdur Mehmet Akif Ersoy University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
6 Years to 10 Years
Sex
All
01

Study summary

The goal of this study is to learn how artificial intelligence-supported digital games and exercise activities affect children with autism spectrum disorder and typically developing children aged 6 to 10 years. The main questions it aims to answer are:

Do the digital game and exercise activities improve children's motor skills? Do the activities affect repetitive behaviors, working memory, and brain activity?

Researchers will compare children who take part in the digital game and exercise activities with children who do not take part in these activities.

Participants will complete assessments before and after the study. Children in the intervention group will take part in artificial intelligence-supported digital game and exercise activities. Researchers will assess children's motor skills, working memory, behaviors, and brain activity.

Read the detailed description

This study will examine the effects of artificial intelligence-supported digital game and exercise applications on children with autism spectrum disorder and typically developing children using a holistic approach. The study will include 60 children aged 6 to 10 years, including 30 children with autism spectrum disorder and 30 typically developing children.

Participants will be assigned to intervention and control groups. The intervention group will include 15 children with autism spectrum disorder and 15 typically developing children. The control group will include 15 children with autism spectrum disorder and 15 typically developing children. Children in the intervention group will participate in artificial intelligence-supported digital game and exercise activities, while children in the control group will not receive this intervention.

The study will examine changes in motor skills, repetitive behaviors, working memory, and brain activity. Quantitative assessments will include standardized measures and electroencephalography (EEG). Qualitative information will also be collected from parents to provide a broader understanding of children's experiences and development.

02

Conditions studied

  • Autism Disorder

Browse trials for

Keywords

  • Artificial Intelligence
  • Digital Games
  • Electroencephalography
03

Who can participate

Ages eligible
6 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children aged 6-10 years.
  • Written informed consent from a parent or legal guardian.
  • Ability to understand and follow simple verbal instructions.
  • Ability to stand independently and perform basic locomotor movements.
  • For participants in the ASD groups: a physician-confirmed diagnosis of autism -spectrum disorder (ASD) with mild to moderate severity.
  • For typically developing participants: typical development without a diagnosis of ASD or another neurodevelopmental disorder.
  • For typically developing participants: no known neurological, orthopedic, or cardiovascular condition that would interfere with participation in the study activities.

Exclusion criteria

Exclusion Criteria:

  • Orthopedic surgery within the previous 6 months.
  • Presence of a neurological, orthopedic, or cardiovascular condition that may limit participation in movement-based activities.
  • An acute health condition that prevents participation in physical activity.
  • For typically developing participants: presence of a diagnosed neurodevelopmental disorder.
  • Inability to complete the planned assessments or participate safely in the study activities.
  • For participants assigned to an intervention group: expected attendance of less than 80% of the planned intervention sessions.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    ASD Intervention Group

    Children with autism spectrum disorder assigned to the intervention group will participate in the artificial intelligence-supported digital game and exercise program.

    Behavioral: Movement-Based Digital Game Intervention

  • No intervention
    ASD Control Group

    Children with autism spectrum disorder assigned to the control group will not participate in the artificial intelligence-supported digital game and exercise intervention.

  • Experimental
    Typically Developing Intervention Group

    Typically developing children assigned to the intervention group will participate in the artificial intelligence-supported digital game and exercise program.

    Behavioral: Movement-Based Digital Game Intervention

  • No intervention
    Typically Developing Control Group

    Typically developing children assigned to the control group will not participate in the artificial intelligence-supported digital game and exercise intervention.

Interventions

  • BehavioralMovement-Based Digital Game Intervention

    The intervention consists of a 10-week movement-based digital game program specifically developed for children aged 6-10 years. Participants in the intervention groups will attend two sessions per week, with each session lasting approximately 60 minutes. Sessions include warm-up, movement-based digital game activities, and cool-down. The digital games are delivered using an interactive projection system and require children to perform active body movements in response to visual and game-based tasks. Activities progressively target balance, coordination, locomotor skills, object control, hand-eye coordination, bilateral coordination, rhythm, reaching, jumping, changing direction, body awareness, and target-directed movements. Game difficulty and movement demands are progressively adjusted throughout the intervention period.

05

What researchers measure

Primary outcomes

  1. Motor Skill Performance

    Motor proficiency in the 30 children with autism spectrum disorder and 30 typically developing children will be assessed using the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition, Short Form (BOT-2 SF). The BOT-2 SF consists of 12 items representing eight motor skill areas: Fine Motor Precision, Fine Motor Integration, Manual Dexterity, Bilateral Coordination, Balance, Running Speed and Agility, Upper-Limb Coordination, and Strength. Raw performance scores for individual items are converted to point scores according to the BOT-2 scoring procedures and summed to obtain a Total Point Score. The BOT-2 SF Total Point Score ranges from 0 to 88. Higher scores indicate better overall motor proficiency, whereas lower scores indicate poorer motor proficiency.

    Time frame: Baseline and immediately after the 10-week intervention

  2. Repetitive Behaviors Assessed With the TEDÖ-R-TV

    Repetitive behaviors in the 30 children with autism spectrum disorder will be assessed using the Repetitive Behavior Scale-Revised-Turkish Version (RBS-R-TV). The scale consists of 43 items covering six domains of repetitive behavior: Stereotyped Behavior, Self-Injurious Behavior, Compulsive Behavior, Ritualistic Behavior, Sameness Behavior, and Restricted Behavior. Each item is rated on a 4-point scale from 0 to 3. The total score ranges from 0 to 129. Higher scores indicate greater severity of repetitive behaviors and, therefore, a worse outcome, whereas lower scores indicate less severe repetitive behaviors.

    Time frame: Baseline and immediately after the 10-week intervention

  3. Working Memory Assessed With the Working Memory Scale (ÇBÖ)

    Working memory will be assessed using the Working Memory Scale (ÇBÖ) developed by Ergül, Özgür-Yılmaz, and Demir. The Working Memory Scale for Children Aged 5-10 Years will be used to assess working memory performance in children with autism spectrum disorder and typically developing children. The scale consists of nine subtests grouped into four dimensions: Verbal Short-Term Memory (Digit Recall, Word Recall, and Nonword Recall), Visual Short-Term Memory (Pattern Matrix and Block Recall), Verbal Working Memory (Backward Digit Recall and First-Word Recall), and Visual Working Memory (Odd-One-Out and Spatial Discrimination). Each item includes two trials, and one point is awarded for each sequence correctly recalled or identified in the required order. The total raw score ranges from 0 to 86, with higher scores indicating better working memory performance.

    Time frame: Baseline and immediately after the 10-week intervention

  4. Brain Activity Assessed With Electroencephalography (EEG)

    Brain activity will be assessed using electroencephalography (EEG) before and after the intervention. EEG recordings will be used to evaluate changes in brain activity associated with the artificial intelligence-supported digital game and exercise intervention.

    Time frame: Baseline and immediately after the 10-week intervention

06

Study locations

1 site
  • Burdur Mehmet Akif Ersoy University
    Burdur, Burdur 15030, Turkey (Türkiye)
07

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to participant privacy and confidentiality considerations. The study involves children, including children with autism spectrum disorder, and the informed consent process does not include provisions for sharing individual-level data with other researchers.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07803172
Lead sponsor
Burdur Mehmet Akif Ersoy University
Responsible party
Sponsor
First posted
Sep 3, 2026
Start date
Sep 30, 2026 (estimated)
Primary completion
Dec 30, 2026 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
Sep 15, 2026

Study contacts

Emine Busra Yılmaz, Ph. D.
Contact
eminebusray@gmail.com
905544819866

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion